Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02431416Completed
Randomised trial of gonadorelin in precocious puberty (2 arms), sponsored by Region Örebro län. Primary endpoint: Ghrelin concentration after GnRH injection and after saline injection. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02431416.